A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Clinical trial NCT03927456 · UNKNOWN
Trial details
- NCT number
- NCT03927456
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-13
- Primary completion
- 2021-12-30
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.